Susan Blum
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Susan Blum is Chief Financial Officer & Executive Vice President at CorMedix, Inc. starting in 2025.
Formerly, Ms. Blum was Independent Director at BiomX, Inc. from 2024 to 2026, Chief Financial Officer at Melinta Therapeutics, Inc. from 2021 to 2025, and Controller at Textura Corp.
from 2013 to 2016.
Education includes undergraduate studies at Santa Clara University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CORMEDIX INC. 0,17 % | 23/01/2026 | 132 739 ( 0,17 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CORMEDIX INC. | Directeur Financier/CFO | 29/08/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMX INC. | Directeur/Membre du Conseil | 24/02/2026 |
| MELINTA THERAPEUTICS, INC. | Directeur Financier/CFO | 29/08/2025 |
| TEXTURA CORP | Comptroller/Controller/Auditor | 01/01/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
CorMedix, Inc.
CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Textura Corp.
Textura Corp. Packaged SoftwareTechnology Services Develops software for real estate developers and contractors construction projects | Technology Services |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national